The FDA rejected AstraZeneca's subcutaneous Saphnelo application, delaying U.S. approval until 2026, despite positive ...
February 3, 2026. The Czech economy continues to expand at a robust pace but faces mounting structural headwinds.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results